223 related articles for article (PubMed ID: 1922139)
21. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
22. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the effect of selenium on the mutagenicity and metabolism of benzo[a]pyrene in rat and hamster liver S9 activation systems.
Teel RW
Cancer Lett; 1984 Oct; 24(3):281-9. PubMed ID: 6388822
[TBL] [Abstract][Full Text] [Related]
24. Base-substitution profiles of externally activated polycyclic aromatic hydrocarbons and aromatic amines determined in a lacZ reversion assay.
Garganta F; Krause G; Scherer G
Environ Mol Mutagen; 1999; 33(1):75-85. PubMed ID: 10037326
[TBL] [Abstract][Full Text] [Related]
25. Cassia senna inhibits mutagenic activities of benzo[a]-pyrene, aflatoxin B1, shamma and methyl methanesulfonate.
al-Dakan AA; al-Tuffail M; Hannan MA
Pharmacol Toxicol; 1995 Oct; 77(4):288-92. PubMed ID: 8577642
[TBL] [Abstract][Full Text] [Related]
26. Rat nasal tissue activation of benzo(a)pyrene and 2-aminoanthracene to mutagens in Salmonella typhimurium.
Bond JA; Li AP
Environ Mutagen; 1983; 5(3):311-8. PubMed ID: 6303770
[TBL] [Abstract][Full Text] [Related]
27. Retinol (vitamin A) as a modifier of 2-aminofluorene and 2-acetyl-aminofluorene mutagenesis in the Salmonella/microsome assay.
Busk L; Ahlborg UG
Arch Toxicol; 1982 Jan; 49(2):169-74. PubMed ID: 7036954
[TBL] [Abstract][Full Text] [Related]
28. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
29. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
30. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
Gatehouse DG; Paes DJ
Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of mutagenic and antimutagenic activities of alpha-bisabolol in the Salmonella/microsome assay.
Gomes-Carneiro MR; Dias DM; De-Oliveira AC; Paumgartten FJ
Mutat Res; 2005 Aug; 585(1-2):105-12. PubMed ID: 15936245
[TBL] [Abstract][Full Text] [Related]
32. Activation of benzo[a]pyrene and 2-aminoanthracene to bacteria mutagens by mussel digestive gland postmitochondrial fraction.
Michel XR; Cassand PM; Narbonne JF
Mutat Res; 1993 Feb; 301(2):113-9. PubMed ID: 7678168
[TBL] [Abstract][Full Text] [Related]
33. The activation of mutagens in diesel particle extract with rat liver S9 enzymes.
Pederson TC; Siak JS
J Appl Toxicol; 1981 Apr; 1(2):61-6. PubMed ID: 6206115
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and mutagenicity of a series of nitrated carbazoles and hydroxycarbazoles.
Holloway TC; Ball LM
Mutagenesis; 1993 Jul; 8(4):321-7. PubMed ID: 8377651
[TBL] [Abstract][Full Text] [Related]
35. Promutagen activation with mammalian and avian S9 liver microsomes.
Tometsko AM; Sheridan KM; DeTraglia MC
J Appl Toxicol; 1981 Feb; 1(1):11-4. PubMed ID: 6309943
[TBL] [Abstract][Full Text] [Related]
36. Effects of metyrapone on microsomal-dependent Salmonella mutagenesis. Studies with chloroallyl ethers and model compounds.
Distlerath LM; Loper JC; Tabor MW
Biochem Pharmacol; 1983 Dec; 32(24):3739-48. PubMed ID: 6661250
[TBL] [Abstract][Full Text] [Related]
37. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
[TBL] [Abstract][Full Text] [Related]
38. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
Wesp HF; Tang X; Edenharder R
Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694
[TBL] [Abstract][Full Text] [Related]
39. Effect of bacterial concentration on reversions induced in Salmonella typhimurium TA1538 by N-hydroxy-2-acetylaminofluorene.
White GL; Beranek DT; Heflich RH
Environ Mutagen; 1983; 5(4):565-75. PubMed ID: 6347679
[TBL] [Abstract][Full Text] [Related]
40. The effect of solvents upon the yield of revertants in the Salmonella/activation mutagenicity assay.
Anderson D; McGregor DB
Carcinogenesis; 1980 Apr; 1(4):363-6. PubMed ID: 6268317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
